Related Experiment Videos

Timing of surgery in congenital diaphragmatic hernia. Low mortality after pre-operative stabilisation

A J Charlton1, J Bruce, M Davenport

  • 1North West Regional Neonatal Surgery Unit, St. Mary's Hospital for Women and Children, Whitworth Park, Manchester.

Anaesthesia
|October 1, 1991
PubMed

Insights

Delayed surgery for congenital diaphragmatic hernia (CDH) in newborns resulted in a 70.9% survival rate. Postmortem analysis suggests extracorporeal membrane oxygenation (ECMO) would not have significantly improved outcomes for these CDH patients.

Area of Science:

  • Neonatal Surgery
  • Pediatric Surgery
  • Congenital Abnormalities

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect impacting infant survival.
  • Optimal timing for surgical intervention in CDH remains a critical clinical question.
  • Neonatal surgical units face challenges in managing CDH cases presenting shortly after birth.

Purpose of the Study:

  • To evaluate the outcomes of a delayed surgical approach for congenital diaphragmatic hernia.
  • To assess the impact of a evolving management policy on patient survival.
  • To determine the potential benefit of extracorporeal membrane oxygenation (ECMO) in improving survival rates for CDH.

Main Methods:

  • Retrospective review of 86 consecutive neonates with CDH presenting within 6 hours of birth.
  • Analysis of patient management under a delayed surgery policy over a 6-year period.
  • Correlation of postmortem findings and exclusion criteria with overall survival data.

Main Results:

  • Overall survival to hospital discharge was 70.9% for the studied CDH cohort.
  • A low rate of postoperative mortality was observed, with only 7 deaths (10.3% of operations).
  • Analysis indicated that ECMO availability would likely have had minimal impact on overall survival rates.

Conclusions:

  • A delayed surgical strategy for congenital diaphragmatic hernia is associated with considerable survival rates.
  • The majority of deaths in CDH patients were attributable to factors unlikely to be mitigated by ECMO.
  • Current management policies for CDH can achieve significant survival benefits without widespread ECMO use.

Related Concept Videos